SENSEX
NIFTY
GOLD
USD/INR

Weather

image 21    C

Company News

The Economic Times

Company / The Economic Times

details

Novartis to buy experimental breast cancer drug in up to $3 billion deal

Swiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal is valued at up to three billion dollars. This acquisition bolsters Novartis's pipeline of targeted cancer therapies. The experimental drug, SNV4818, targets a specific type of breast cancer.

20 Mar 2026 3:52 pm